OAM
TBIO

Oxford Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Oxford Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,551
Closed -$110K – 1604
2019
Q4 		$110K Buy
+13,551
New +$125K ﹤0.01% 1613
2019
Q2 		– Sell
-11,322
Closed -$115K – 2048
2019
Q1 		$115K Buy
+11,322
New +$86.8K ﹤0.01% 1560

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Oxford Asset Management's TBIO Position: Q1 2020 in Review

Oxford Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2020, closing a stake of 13,551 shares — an estimated $110K sold.

Oxford Asset Management first reported a position in TBIO in Q1 2019 and held it in 2 quarters. The position peaked at $115K in Q1 2019. 74 funds tracked by Wall St. Rank hold TBIO as of Q1 2020.

  • Oxford Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 13,551 Translate Bio, Inc. Common Stock shares in Q1 2020, an estimated $110K.
  • Oxford Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Oxford Asset Management's Translate Bio, Inc. Common Stock position peaked at $115K in Q1 2019.
  • 74 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.